Metrics as of 10/15/2026, 03:47 AM (Berlin time), refresh in progress.
Penumbra Stock
Penumbra, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- Adam Elsesser
- Employees
- 4,700
- Market cap
- $12.6 B
- IPO
- 18/09/2015
Penumbra, Inc., headquartered in Alameda, USA, is a healthcare company operating within the medical devices industry. Founded in 2004, the company designs, develops, manufactures, and markets medical devices both in the United States and internationally. Its product portfolio includes computer-assisted vacuum…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Penumbra stock: price history
1D
+0.0%
1W
+1.2%
1M
+0.1%
6M
-3.7%
YTD
+3.0%
1Y
+25.6%
2Y
+51.5%
5Y
+19.6%
10Y
+351.3%
Next earnings date
Next earnings date
04/11/2026 (in 18 days)
Volatility around earnings
~40% stronger price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vsqueeze-release-v1.0 on 12/10/26. Not a buy or sell signal.Beta
What does this mean?
Volatility squeeze
BullishPrice swings had compressed unusually tight beforehand (volatility near a low) and are now releasing into a stronger move. Technical analysis views such tight phases as often preceding a bigger move.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Ask the agents about Penumbra
Analyst assessment of Penumbra
PRICE TARGET LOW
US$320.00
CONSENSUS
US$320.00
MEDIAN
US$320.00
PRICE TARGET HIGH
US$320.00
0
STRONG BUY
9
BUY
13
HOLD
0
SELL
0
STRONG SELL
22
TOTAL · Hold
As of: 06/07/2026
Penumbra stock metrics
P/E
78.27
P/B
8.22
EV/EBITDA
56.76
RETURN ON EQUITY
2.3%
NET MARGIN
8.9%
DEBT/EQUITY
0.14
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
97.2%
FLOAT SHARES
38,274,307
AVG. DAILY VOLUME (30D)
363,291
Insider transactions (SEC)
Narayan Shruthi
Narayan Shruthi
Narayan Shruthi
Elsesser Adam
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: +0.0%
Forums (Reddit)
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about Penumbra stock
What does Penumbra do?
Penumbra, Inc. is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Adam Elsesser, the company employs around 4,700 people.
The IPO was on 18/09/2015; the stock trades on NYSE under the ticker PEN.
What do analysts say about Penumbra stock?
22 analysts rate the stock, the consensus is Hold (as of 06/07/2026).
The average price target is US$320.00, ranging from US$320.00 to US$320.00, with a median of US$320.00.
This is an external assessment, not a statement by Market Jury.
When does Penumbra report next?
The next earnings date is 04/11/2026.
Around past earnings, price swings were roughly 40% stronger than usual.
Does Penumbra pay a dividend?
No, Penumbra currently does not pay a dividend.
Which stocks are comparable to Penumbra?
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
How can I get Penumbra stock analyzed?
Clicking "Analyze stock" lets five strategies assess Penumbra against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.